Literature DB >> 2684155

Regulation of very-low-density-lipoprotein lipid secretion in hepatocyte cultures derived from diabetic animals.

J M Duerden1, S M Bartlett, G F Gibbons.   

Abstract

Hepatocytes were derived from 2-3-day streptozotocin-diabetic rats and maintained in culture for up to 3 days. Compared with similar cultures from normal animals, these hepatocytes secreted less very-low-density-lipoprotein (VLDL) triacylglycerol, but the decrease in the secretion of VLDL non-esterified and esterified cholesterol was not so pronounced. This resulted in the secretion of relatively cholesterol-rich VLDL particles by the diabetic hepatocytes. Addition of insulin for a relatively short period (24 h) further decreased the low rates of VLDL triacylglycerol secretion from the diabetic hepatocytes. The secretion of VLDL esterified and non-esterified cholesterol also declined. These changes occurred irrespective of whether or not exogenous fatty acids were present in the culture medium. Little or no inhibitory effect of insulin was observed after longer-term (24-48 h) exposure to the hormone. Both dexamethasone and a mixture of lipogenic precursors (lactate plus pyruvate) stimulated VLDL triacylglycerol and cholesterol secretion, but not to the levels observed in hepatocytes from normal animals. The low rate of hepatic VLDL secretion in diabetes contrasts with the increase in whole-body VLDL production rate. This suggests that the intestine is a major source of plasma VLDL in insulin-deficient diabetes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684155      PMCID: PMC1133262          DOI: 10.1042/bj2620313

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  Intestinal very low density lipoprotein secretion in insulin-deficient rats.

Authors:  T R Risser; G M Reaven; E P Reaven
Journal:  Diabetes       Date:  1978-09       Impact factor: 9.461

2.  Relationship between activity of hepatic 3-hydroxy-3-methylglutaryl-coenzyme A reductase and secretion of very-low-density-lipoprotein cholesterol by the isolated perfused liver and in the intact rat.

Authors:  E H Goh; M Heimberg
Journal:  Biochem J       Date:  1979-10-15       Impact factor: 3.857

Review 3.  Physiology and pathophysiology of glucagon.

Authors:  R H Unger; L Orci
Journal:  Physiol Rev       Date:  1976-10       Impact factor: 37.312

4.  Intestinal contribution to secretion of very low density lipoproteins into plasma.

Authors:  T R Risser; G M Reaven; E P Reaven
Journal:  Am J Physiol       Date:  1978-03

5.  Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.

Authors:  J E Gerich; M Langlois; C Noacco; M Lorenzi; J H Karam; P H Korsham
Journal:  J Clin Invest       Date:  1976-08       Impact factor: 14.808

6.  Triton-induced hyperlipidemia: a model for studies of intestinal lipoprotein production.

Authors:  P R Holt; A A Dominguez
Journal:  Am J Physiol       Date:  1980-05

7.  Hepatic production of VLDL-triglycerides. Dependence of portal substrate and insulin concentration.

Authors:  K H Vogelberg; F A Gries; D Moschinski
Journal:  Horm Metab Res       Date:  1980-12       Impact factor: 2.936

8.  Serum lipoproteins of diabetic rats fed a high cholesterol diet.

Authors:  C M Arbeeny; D Edelstein; S R Freedman; H A Eder
Journal:  Diabetes       Date:  1980-10       Impact factor: 9.461

9.  Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia.

Authors:  M Greenfield; O Kolterman; J Olefsky; G M Reaven
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

10.  Evidence for multiple causality in the development of diabetic hypertriglyceridaemia.

Authors:  D Weiland; C E Mondon; G M Reaven
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

View more
  13 in total

1.  The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density lipoprotein and its response to hormones and sulphonylureas.

Authors:  D Wiggins; G F Gibbons
Journal:  Biochem J       Date:  1992-06-01       Impact factor: 3.857

2.  Decreased secretion of very-low-density lipoprotein triacylglycerol and apolipoprotein B is associated with decreased intracellular triacylglycerol lipolysis in hepatocytes derived from rats fed orotic acid or n-3 fatty acids.

Authors:  A M Hebbachi; M C Seelaender; B W Baker; G F Gibbons
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

3.  Solubilization and separation of two distinct carnitine acyltransferases from hepatic microsomes: characterization of the malonyl-CoA-sensitive enzyme.

Authors:  N M Broadway; E D Saggerson
Journal:  Biochem J       Date:  1995-09-15       Impact factor: 3.857

Review 4.  Triglycerides and disease.

Authors:  C A Seymour; C D Byrne
Journal:  Postgrad Med J       Date:  1993-09       Impact factor: 2.401

5.  Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone.

Authors:  P Martin-Sanz; J E Vance; D N Brindley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  Triacylglycerol accumulation and secretion in hepatocyte cultures. Effects of insulin, albumin and Triton WR 1339.

Authors:  N Emmison; V A Zammit; L Agius
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

7.  Restoration in vitro of normal rates of very-low-density lipoprotein triacylglycerol and apoprotein B secretion in hepatocyte cultures from diabetic rats.

Authors:  J M Duerden; G F Gibbons
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

8.  Biphasic effects of glucagon and cyclic AMP on the synthesis and secretion of lipids by rat hepatocytes.

Authors:  D Hermier; P Hales; D N Brindley
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

9.  Impaired hepatic apolipoprotein B and E translation in streptozotocin diabetic rats.

Authors:  J D Sparks; R Zolfaghari; C E Sparks; H C Smith; E A Fisher
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

10.  Plasminogen activator inhibitor-1 synthesis in the human hepatoma cell line Hep G2. Metformin inhibits the stimulating effect of insulin.

Authors:  F Anfosso; N Chomiki; M C Alessi; P Vague; I Juhan-Vague
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.